Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1974 1
1980 2
1984 2
1985 1
1991 1
1993 1
1994 1
1995 2
1999 1
2000 1
2002 1
2003 3
2004 2
2005 2
2007 3
2008 5
2009 14
2010 7
2011 7
2012 10
2013 7
2014 10
2015 13
2016 14
2017 16
2018 17
2019 25
2020 25
2021 7
Text availability
Article attribute
Article type
Publication date

Search Results

184 results
Results by year
Filters applied: . Clear all
Page 1
Recommendations for buprenorphine and methadone therapy in opioid use disorder: a European consensus.
Dematteis M, Auriacombe M, D'Agnone O, Somaini L, Szerman N, Littlewood R, Alam F, Alho H, Benyamina A, Bobes J, Daulouede JP, Leonardi C, Maremmani I, Torrens M, Walcher S, Soyka M. Dematteis M, et al. Expert Opin Pharmacother. 2017 Dec;18(18):1987-1999. doi: 10.1080/14656566.2017.1409722. Epub 2017 Dec 3. Expert Opin Pharmacother. 2017. PMID: 29183228 Review.
Management of patients with opioid use disorder (OUD) commonly includes opioid agonist therapy (OAT) as a part of an integrated treatment plan. ...Expert opinion: Pharmacotherapy is recommended as part of an integrated OUD treatment approach wit …
Management of patients with opioid use disorder (OUD) commonly includes opioid agonist therapy (OAT) as a part of an in …
Opioid prescribing: a systematic review and critical appraisal of guidelines for chronic pain.
Nuckols TK, Anderson L, Popescu I, Diamant AL, Doyle B, Di Capua P, Chou R. Nuckols TK, et al. Ann Intern Med. 2014 Jan 7;160(1):38-47. doi: 10.7326/0003-4819-160-1-201401070-00732. Ann Intern Med. 2014. PMID: 24217469 Free PMC article. Review.
BACKGROUND: Deaths due to prescription opioid overdoses have increased dramatically. High-quality guidelines could help clinicians mitigate risks associated with opioid therapy. ...Most guidelines recommend that clinicians avoid doses greater than 90 to 200 m …
BACKGROUND: Deaths due to prescription opioid overdoses have increased dramatically. High-quality guidelines could help clinicians mi …
American Society of Addiction Medicine (ASAM) National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use.
Kampman K, Jarvis M. Kampman K, et al. J Addict Med. 2015 Sep-Oct;9(5):358-67. doi: 10.1097/ADM.0000000000000166. J Addict Med. 2015. PMID: 26406300 Free PMC article.
This "Practice Guideline" was developed to assist in the evaluation and treatment of opioid use disorder, and in the hope that, using this tool, more physicians will be able to provide effective treatment. Although there are existing guidelines for the tre
This "Practice Guideline" was developed to assist in the evaluation and treatment of opioid use disorder, and in the hope that …
Buprenorphine Formulations: Clinical Best Practice Strategies Recommendations for Perioperative Management of Patients Undergoing Surgical or Interventional Pain Procedures.
Jonan AB, Kaye AD, Urman RD. Jonan AB, et al. Pain Physician. 2018 Jan;21(1):E1-E12. Pain Physician. 2018. PMID: 29357325 Free article. Review.
BACKGROUND: Starting with approval for clinical use in the treatment of opioid dependence in October 2002 by the Food and Drug Administration (FDA), buprenorphine has become an integral treatment option and in recent years, in chronic pain management. …
BACKGROUND: Starting with approval for clinical use in the treatment of opioid dependence in October 2002 by the Food a …
Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain.
Chou R, Fanciullo GJ, Fine PG, Adler JA, Ballantyne JC, Davies P, Donovan MI, Fishbain DA, Foley KM, Fudin J, Gilson AM, Kelter A, Mauskop A, O'Connor PG, Passik SD, Pasternak GW, Portenoy RK, Rich BA, Roberts RG, Todd KH, Miaskowski C; American Pain Society-American Academy of Pain Medicine Opioids Guidelines Panel. Chou R, et al. J Pain. 2009 Feb;10(2):113-30. doi: 10.1016/j.jpain.2008.10.008. J Pain. 2009. PMID: 19187889 Free PMC article.
However, opioids are also associated with potentially serious harms, including opioid-related adverse effects and outcomes related to the abuse potential of opioids. ...PERSPECTIVE: Safe and effective chronic opioid therapy for chronic no …
However, opioids are also associated with potentially serious harms, including opioid-related adverse effects and outcomes rel …
Guideline for opioid therapy and chronic noncancer pain.
Busse JW, Craigie S, Juurlink DN, Buckley DN, Wang L, Couban RJ, Agoritsas T, Akl EA, Carrasco-Labra A, Cooper L, Cull C, da Costa BR, Frank JW, Grant G, Iorio A, Persaud N, Stern S, Tugwell P, Vandvik PO, Guyatt GH. Busse JW, et al. CMAJ. 2017 May 8;189(18):E659-E666. doi: 10.1503/cmaj.170363. CMAJ. 2017. PMID: 28483845 Free PMC article. No abstract available.
Comparison of Opioids Prescribed for Patients at Risk for Opioid Misuse Before and After Publication of the Centers for Disease Control and Prevention's Opioid Prescribing Guidelines.
Scherrer JF, Tucker J, Salas J, Zhang Z, Grucza R. Scherrer JF, et al. JAMA Netw Open. 2020 Dec 1;3(12):e2027481. doi: 10.1001/jamanetworkopen.2020.27481. JAMA Netw Open. 2020. PMID: 33263762 Free PMC article.
OBJECTIVES: To compare the odds of new Schedule II opioid (codeine, hydrocodone, oxycodone) prescriptions vs Schedule IV opioid (tramadol) prescriptions in the 18-month periods before and after the CDC guideline release to determine wheth …
OBJECTIVES: To compare the odds of new Schedule II opioid (codeine, hydrocodone, oxycodone) prescriptions vs Sch …
Treating Perioperative and Acute Pain in Patients on Buprenorphine: Narrative Literature Review and Practice Recommendations.
Buresh M, Ratner J, Zgierska A, Gordin V, Alvanzo A. Buresh M, et al. J Gen Intern Med. 2020 Dec;35(12):3635-3643. doi: 10.1007/s11606-020-06115-3. Epub 2020 Aug 21. J Gen Intern Med. 2020. PMID: 32827109 Review.
Opioid use disorder (OUD), a leading cause of morbidity and mortality in the USA, can be effectively treated with buprenorphine. However, the same pharmacologic properties (e.g., high affinity, partial agonism, long half-life) that make it ideal as a treatment for O
Opioid use disorder (OUD), a leading cause of morbidity and mortality in the USA, can be effectively treated with buprenorphine. Howe
Abuse liability assessment of hydrocodone under current draft regulatory guidelines.
Gauvin DV, McComb M, Code R, Dalton JA, Baird TJ. Gauvin DV, et al. J Pharmacol Toxicol Methods. 2015 Sep-Oct;75:118-29. doi: 10.1016/j.vascn.2015.05.003. Epub 2015 May 9. J Pharmacol Toxicol Methods. 2015. PMID: 25969422
Food & Drug Administration draft guidelines for the non-clinical investigation of the dependence potential of medicinal products. METHODS: Self-administration, drug discrimination, and repeat-dose two week dependence liability studies were conducted to compare …
Food & Drug Administration draft guidelines for the non-clinical investigation of the dependence potential of medicinal products. …
Methadone safety: a clinical practice guideline from the American Pain Society and College on Problems of Drug Dependence, in collaboration with the Heart Rhythm Society.
Chou R, Cruciani RA, Fiellin DA, Compton P, Farrar JT, Haigney MC, Inturrisi C, Knight JR, Otis-Green S, Marcus SM, Mehta D, Meyer MC, Portenoy R, Savage S, Strain E, Walsh S, Zeltzer L; American Pain Society; Heart Rhythm Society. Chou R, et al. J Pain. 2014 Apr;15(4):321-37. doi: 10.1016/j.jpain.2014.01.494. J Pain. 2014. PMID: 24685458
Methadone is used for the treatment of opioid addiction and for treatment of chronic pain. ...The American Pain Society and the College on Problems of Drug Dependence, in collaboration with the Heart Rhythm Society, commissioned an interd
Methadone is used for the treatment of opioid addiction and for treatment of chronic pain. ...The America
184 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page